137 related articles for article (PubMed ID: 20827796)
1. German health reform compromise under attack.
Hyde R
Lancet; 2010 Sep; 376(9743):759-60. PubMed ID: 20827796
[No Abstract] [Full Text] [Related]
2. An Rx for reform: a Medicare prescription drug benefit.
Rak J
Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
[No Abstract] [Full Text] [Related]
3. These doctor's mission: keeping drug costs down.
Guglielmo WJ
Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
[No Abstract] [Full Text] [Related]
4. Lowering the cost of prescription drugs.
Jindal B
J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
[No Abstract] [Full Text] [Related]
5. States form coalitions to leverage lower prescription drug prices.
Young D
Am J Health Syst Pharm; 2002 Jan; 59(1):20-1. PubMed ID: 11813461
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
[No Abstract] [Full Text] [Related]
7. Prescription drugs and health care reform.
Gibaldi M
Pharmacotherapy; 1993; 13(6):583-9. PubMed ID: 8302681
[No Abstract] [Full Text] [Related]
8. Pharmaceutical Research and Manufacturers of America v. Walsh: the Supreme Court allows the states to proceed with expanding access to drugs.
Jost TS
Yale J Health Policy Law Ethics; 2004; 4(1):69-84. PubMed ID: 15052860
[No Abstract] [Full Text] [Related]
9. Comparative experience in home care and pharmaceutical policy.
Kane NM; Saltman RB
Health Policy; 1997 Sep; 41 Suppl():S1-7. PubMed ID: 10174467
[No Abstract] [Full Text] [Related]
10. Health reform: facing the future. Setting up health insurance exchanges is one of the big, early tasks for lawmakers.
Brand R
State Legis; 2010; 36(9):22-6. PubMed ID: 21061731
[No Abstract] [Full Text] [Related]
11. Pharma 2020--An Economist Conference Shaping the Future of the Pharmaceuticals Industry.
Kibble A
IDrugs; 2008 May; 11(5):331-3. PubMed ID: 18465672
[No Abstract] [Full Text] [Related]
12. Clinton team works with drug companies to expand access, restrict costs.
Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
[No Abstract] [Full Text] [Related]
13. Controlling the cost of prescription drugs.
White JR
Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498
[No Abstract] [Full Text] [Related]
14. How will drug and device makers fare under Clinton's reform plan?
Blankenau R
Mater Manag Health Care; 1993 Nov; 2(11):18, 20. PubMed ID: 10129563
[No Abstract] [Full Text] [Related]
15. Pharmaceutical industry.
Lewis L
State Health Care Am; 1994; ():23-7. PubMed ID: 10133845
[TBL] [Abstract][Full Text] [Related]
16. Affordable prescription drugs--state and federal action.
Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
[No Abstract] [Full Text] [Related]
17. State trends in the cost of employer health insurance coverage, 2003-2013.
Schoen C; Radley D; Collins SR
Issue Brief (Commonw Fund); 2015 Jan; 1():1-22. PubMed ID: 25590096
[TBL] [Abstract][Full Text] [Related]
18. Are pharmaceuticals cost-effective? A review of the evidence.
Neumann PJ; Sandberg EA; Bell CM; Stone PW; Chapman RH
Health Aff (Millwood); 2000; 19(2):92-109. PubMed ID: 10718025
[TBL] [Abstract][Full Text] [Related]
19. Patent nonsense: evidence tells of an industry out of social control.
Mintzberg H
CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900
[No Abstract] [Full Text] [Related]
20. Health insurance coverage in Central and Eastern Europe: trends and challenges.
Waters HR; Hobart J; Forrest CB; Siemens KK; Pittman PM; Murthy A; Vanderver GB; Anderson GF; Morlock LL
Health Aff (Millwood); 2008; 27(2):478-86. PubMed ID: 18332505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
